Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer
- PMID: 23983240
- PMCID: PMC3818310
- DOI: 10.1158/1055-9965.EPI-13-0209
Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer
Abstract
Background: Experimental evidence has demonstrated an antineoplastic role for vitamin D in the colon, and higher circulating 25-hydroxyvitamin D [25(OH)D] levels are consistently associated with a lower risk of colorectal cancer. Genome-wide association studies have identified loci associated with levels of circulating 25(OH)D. The identified single-nucleotide polymorphisms (SNPs) from four gene regions collectively explain approximately 5% of the variance in circulating 25(OH)D.
Methods: We investigated whether five polymorphisms in GC, CYP2R1, CYP24A1, and DHCR7/NADSYN1, genes previously shown to be associated with circulating 25(OH)D levels, were associated with colorectal cancer risk in 10,061 cases and 12,768 controls drawn from 13 studies included in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and Colon Cancer Family Registry (CCFR). We conducted a meta-analysis of crude and multivariate-adjusted logistic regression models to calculate odds ratios and associated confidence intervals for SNPs individually, SNPs simultaneously, and for a vitamin D additive genetic risk score (GRS).
Results: We did not observe a statistically significant association between the 25(OH)D-associated SNPs and colorectal cancer marginally, conditionally, or as a GRS, or for colon or rectal cancer separately.
Conclusions: Our findings do not support an association between SNPs associated with circulating 25(OH)D and risk of colorectal cancer. Additional work is warranted to investigate the complex relationship between 25(OH)D and colorectal cancer risk.
Impact: There was no association observed between genetic markers of circulating 25(OH)D and colorectal cancer. These genetic markers account for a small proportion of the variance in 25(OH)D.
©2013 AACR.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Howlader NNA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, editors. SEER Cancer Statistics Review. National Cancer Institute; Bethesda, MD: 2011. based on November 2010 SEER data submission, posted to the SEER web site.
-
- Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003. - PubMed
-
- Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol. 2006;59:114–24. - PubMed
-
- Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res. 2007;13:356–61. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HG004438/HG/NHGRI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- U01 CA164930/CA/NCI NIH HHS/United States
- U24 CA074806/CA/NCI NIH HHS/United States
- R01 CA48998/CA/NCI NIH HHS/United States
- P01 CA 055075/CA/NCI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- R01 CA042182/CA/NCI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- CA167552/CA/NCI NIH HHS/United States
- K07 CA148894/CA/NCI NIH HHS/United States
- R01 CA059045/CA/NCI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- R01 CA60987/CA/NCI NIH HHS/United States
- P01CA087969/CA/NCI NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- P30 DK043351/DK/NIDDK NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- Z01 CP010200/ImNIH/Intramural NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- R01 137178/PHS HHS/United States
- CAPMC/ CIHR/Canada
- R01 CA048998/CA/NCI NIH HHS/United States
- R25 CA094880/CA/NCI NIH HHS/United States
- U01 CA137088/CA/NCI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- R37 CA54281/CA/NCI NIH HHS/United States
- K24 DK098311/DK/NIDDK NIH HHS/United States
- P50CA127003/CA/NCI NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- R01 CA060987/CA/NCI NIH HHS/United States
- U01 CA097735/CA/NCI NIH HHS/United States
- CA42182/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- K05 CA152715/CA/NCI NIH HHS/United States
- UM1 CA167551/CA/NCI NIH HHS/United States
- U01 CA122839/CA/NCI NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- R01 CA63464/CA/NCI NIH HHS/United States
- U01 CA074806/CA/NCI NIH HHS/United States
- U24 CA074800/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- U01CA074783/CA/NCI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- U01 CA074800/CA/NCI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
